Tapinarof-WBI-1001-DataSheet-MedChemExpress_第1页
Tapinarof-WBI-1001-DataSheet-MedChemExpress_第2页
Tapinarof-WBI-1001-DataSheet-MedChemExpress_第3页
Tapinarof-WBI-1001-DataSheet-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemETapinarofCat. No.: HY-109044CAS No.: 79338-84-4Synonyms: WBI 1001; Benvitimod; GSK2894512分式: CHO分量: 254.32作靶点: Aryl Hydrocarbon Receptor作通路: Immunology/Inflammation储存式: 4C, protect from light* In solvent : -80C, 6 months; -20C,

2、1 month (protect fromlight)溶解性数据体外实验 DMSO : 125 mg/mL (491.51 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 3.9321 mL 19.6603 mL 39.3205 mL5 mM 0.7864 mL 3.9321 mL 7.8641 mL10 mM 0.3932 mL 1.9660 mL 3.9321 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。

3、体内实验请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (9.83 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL

4、 (9.83 mM); Clear solution3. 请依序添加每种溶剂: 10% DMSO 90% corn oil1/2 Master of Small Molecules 您边的抑制剂师www.MedChemESolubility: 2.5 mg/mL (9.83 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Tapinarof种天然的芳烃受体 (AhR) 激动剂,EC50 为 13 nM。IC50 & Target EC50: 13 nM (AhR) 1体外研究 Tapinarof activates the AhR pathway throu

5、gh direct binding. Tapinarof dose-dependently induces nucleartranslocation of AhR in immortalized keratinocytes (HaCaT) (EC50=0.16 nM) 1.体内研究 Tapinarof acts through AhR to reduce inflammation in IMQ-treated mice. AhR-sufficient mice on a C57Bl/6background exhibit a reduced clinical score after treat

6、ment with Tapinarof or 6-formylindolo(3,2-b)carbazole(FICZ). In contrast, AhR KO mice do not respond to the anti-inflammatory effects of Tapinarof. FICZ is usedas a comparator in these studies and yields similar results, with dramatically reduced inflammatoryresponses in wild-type, but not AhR KO mi

7、ce 1.PROTOCOLCell Assay 1 HaCaT cells (10,000 cells/well) are cultured in 96-well Greiner CLEAR plates in 100 L DMEM with HEPES,Glutamax and 10% fetal bovine serum to confluence. Media is replaced with 100 L media containing 0.2%heat-inactivated, charcoal-stripped fetal bovine serum and incubated ov

8、ernight. Titrating concentrations ofTapinarof (10-8 M ,10-6 M, 10-4 M, 0.01 M, and 1 M) are added for 30 minutes followed by washingand fixing in ice-cold methanol:acetone (50:50). Samples are blocked with 3% BSA for 1 hour, and thenwashed again in phosphate buffered saline with 0.1% Tween-20. Next,

9、 cells are stained with 50 L of 1:50dilution anti-AhR antibody in 3% BSA, followed by 50 L secondary antibody (1:500 dilution chicken anti-rabbit AlexaFluor488 and 1:2,000 dilution Hoechst 33342) in 3% BSA/phosphate buffered saline. Images areacquired on InCell 2000 and/or Opera. Image analysis is p

10、erformed using InCell Analyzer Workstation and/orColumbus 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 1Administration 1 Female BALB/c mice (BALB/cByJRj) are used. Studies are performed using 100 L of Tapinarof (1%) orFICZ (0.01%, at th

11、e limit of solubility) in 60% ethanol: 40% water 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Smith SH, et al. Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans. J Invest Dermatol. 2017Oct;137(10):2110-2119.McePdfHeight2/2 Master of Small Molecules 您边的抑制剂师www.MedChemECaution: Product has n

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论